| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.50▼ | 1.50▼ | 1.43▼ | 1.48▼ |
| MA10 | 1.52▼ | 1.51▼ | 1.51▼ | 1.42▼ | 1.54▼ |
| MA20 | 1.52▼ | 1.49▲ | 1.45▲ | 1.48▼ | 1.79▼ |
| MA50 | 1.44▲ | 1.45▲ | 1.46▲ | 1.56▼ | 2.83▼ |
| MA100 | 1.46▲ | 1.50▼ | 1.53▼ | 1.84▼ | 2.51▼ |
| MA200 | 1.53▼ | 1.56▼ | 1.56▼ | 2.57▼ | 1.84▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.003▼ | 0.006▲ | 0.000▼ | 0.019▲ |
| RSI | 50.369▲ | 51.835▲ | 54.310▲ | 41.939▼ | 30.839▼ |
| STOCH | 9.804▼ | 9.804▼ | 38.401 | 30.471 | 16.506▼ |
| WILL %R | -100.000▼ | -100.000▼ | -40.909 | -75.556▼ | -87.500▼ |
| CCI | -97.222 | -102.926▼ | 9.223 | -69.699 | -115.790▼ |
|
Thursday, September 24, 2026 03:00 PM
IMUNON, Inc. hat ein Update zu seinem Entwicklungsprogramm IMNN-001 für Frauen mit neu diagnostiziertem fortgeschrittenem Eierstockkrebs präsentiert. Das Programm umfasst die ...
|
|
Thursday, September 24, 2026 05:05 AM
Imunon, Inc. (Nasdaq: IMNN) presented updated clinical data for its IMNN-001 immunotherapy program at an R&D Day event, highlighting final overall survival results from its randomized Phase ...
|
|
Thursday, September 24, 2026 05:05 AM
Review of final Randomized Phase 2 overall survival results Supportive Preliminary MRD Study Data and translational findings Pathway to confirmatory readout in OVATION 3 Testimonial conversation with ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/26 | 1.34 | 1.4495 | 1.34 | 1.41 | 86,203 |
| 24/09/26 | 1.44 | 1.445 | 1.30 | 1.35 | 184,028 |
| 23/09/26 | 1.54 | 1.57 | 1.418 | 1.47 | 207,244 |
| 22/09/26 | 1.43 | 1.59 | 1.43 | 1.51 | 326,882 |
| 21/09/26 | 1.36 | 1.4741 | 1.35 | 1.43 | 112,675 |
| 18/09/26 | 1.40 | 1.42 | 1.33 | 1.36 | 62,700 |
| 17/09/26 | 1.41 | 1.4378 | 1.35 | 1.38 | 109,218 |
| 16/09/26 | 1.40 | 1.48 | 1.38 | 1.41 | 73,200 |
| 15/09/26 | 1.44 | 1.55 | 1.40 | 1.40 | 61,445 |
| 14/09/26 | 1.49 | 1.53 | 1.41 | 1.465 | 84,321 |
|
|
||||
|
|
||||
|
|